Interventions to increase use of nicotine gum: A randomized, controlled, single-blind trial

被引:37
作者
Mooney, M
Babb, D
Jensen, J
Hatsukami, D
机构
[1] Univ Texas, Subst Abuse Res Ctr, Dept Psychiat & Behav Sci, Houston, TX 77030 USA
[2] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA
关键词
D O I
10.1080/14622200500185637
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Medication noncompliance with smoking cessation pharmacotherapies is a significant problem in both research and clinical settings. This randomized, controlled, single-blind study compared three single-session psychological interventions to increase use of nicotine gum during a 15-day treatment period. A total of 97 adult smokers were randomized to receive standard treatment (ST, n=31), brief feedback (BF, n=32) plus ST, or contingency management (CM; i.e., payment for chewing at least 12 pieces/day on 10 of 15 intervention days, n=34) plus ST and BF. Only the CM condition led to significantly greater average daily gum use (pieces/day: ST, 6.17; BF, 7.81; CM, 10.17 [p values <.05]) and higher rates of compliance (ST, 13.6%; BF, 25.2%; CM, 65.6% [p values <.001]). No differences were observed in smoking abstinence, nicotine withdrawal, or urinary cotinine as a function of treatment. Implications of the present findings are discussed, including application to clinical trials and extension to real-world use of nicotine gum.
引用
收藏
页码:565 / 579
页数:15
相关论文
共 96 条
[1]  
ABRAMS DB, 1998, HDB HLTH BEHAV CHANG, P137
[2]   Nicodermal patch adherence and its correlates [J].
Alterman, AI ;
Gariti, P ;
Cook, TG ;
Cnaan, A .
DRUG AND ALCOHOL DEPENDENCE, 1999, 53 (02) :159-165
[3]   SELF-EFFICACY - TOWARD A UNIFYING THEORY OF BEHAVIORAL CHANGE [J].
BANDURA, A .
PSYCHOLOGICAL REVIEW, 1977, 84 (02) :191-215
[4]   DETERMINANTS OF NICOTINE INTAKE WHILE CHEWING NICOTINE POLACRILEX GUM [J].
BENOWITZ, NL ;
JACOB, P ;
SAVANAPRIDI, C .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (04) :467-473
[5]   Transdermal nicotine: The long and the short of it [J].
Bolin, LJ ;
Antonuccio, DO ;
Follette, WC ;
Krumpe, P .
PSYCHOLOGY OF ADDICTIVE BEHAVIORS, 1999, 13 (02) :152-156
[6]  
BURTON SL, 1998, MOBIDITY MORTALITY W, V49, P665
[7]  
BURTON SL, 1997, MMWR-MORBID MORTAL W, V46, P867
[8]  
CARON HS, 1985, J HYPERTENS, V3, P11
[9]   Contingency management to enhance naltrexone treatment of opioid dependence: A randomized clinical trial of reinforcement magnitude [J].
Carroll, KM ;
Sinha, R ;
Nich, C ;
Babuscio, T ;
Rounsaville, BJ .
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2002, 10 (01) :54-63
[10]   Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence -: Efficacy of contingency management and significant other involvement [J].
Carroll, KM ;
Ball, SA ;
Nich, C ;
O'Connor, PG ;
Eagan, DA ;
Frankforter, TL ;
Triffleman, EG ;
Shi, J ;
Rounsaville, BJ .
ARCHIVES OF GENERAL PSYCHIATRY, 2001, 58 (08) :755-761